Trials / Completed
CompletedNCT06433661
A Research Study of the Effect of Food on Etavopivat in Healthy Participants
A Single-centre, Open-label, Randomised, Single-dose, Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of Etavopivat in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the effect of food on the amount of etavopivat in the bloodstream of healthy participants. Participants will take a single oral dose of etavopivat following a high-fat meal (i.e. fed) and on an empty stomach (i.e fasted) on two separate occasions.The study will last up to 50 days (including screening).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Etavopivat | Participants will receive single dose of oral Etavopivat in each treatment period. |
Timeline
- Start date
- 2024-05-28
- Primary completion
- 2024-07-06
- Completion
- 2024-07-08
- First posted
- 2024-05-30
- Last updated
- 2025-10-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06433661. Inclusion in this directory is not an endorsement.